OTC:PTIX | Cash Flow Statement | Protagenic Therapeutics, Inc.\new

Complete source-backed cash-flow history.

Available history
2010-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$963,616.00-$944,298.00
2026-03-31$5.08M$265,533.00-$313,297.00-$533,898.00
2025-12-31$2.21M
2025-09-30-$869,496.00
2025-06-30-$5.06M-$1.75M$943,180.00$5.01M
2025-03-31-$1.83M-$851,400.00-$394,077.00
2024-12-31-$850,287.00-$819,791.00$0.00$1.6M
2024-09-30-$582,387.00
2024-06-30-$324,355.00
2024-03-31-$1.72M-$1.66M$1.2M
2023-12-31-$1.68M-$1.14M$2.28M
2023-09-30-$1.4M
2023-06-30-$1.21M
2023-03-31-$718,096.00-$371,834.00$294,669.00
2022-12-31-$601,374.00-$180,936.00$161,766.00
2022-09-30-$925,305.00
2022-06-30-$666,717.00
2022-03-31-$1.36M-$430,565.00$370,763.00
2021-12-31-$890,387.00-$405,089.00$485,946.00$0.00
2021-09-30-$878,299.00
2021-06-30-$1.55M
2021-03-31-$1.21M-$607,707.00$127,125.00
2020-12-31-$523,652.00-$320,868.00$0.00
2020-09-30-$1.05M
2020-06-30-$480,386.00
2020-03-31-$498,589.00-$364,406.00$330,000.00
2019-12-31-$749,866.00-$149,420.00$0.00
2019-09-30-$123,307.00
2019-06-30-$278,506.00
2019-03-31-$599,232.00-$196,015.00$250,000.00
2018-12-31-$789,662.00-$307,792.00$245,501.00
2018-09-30-$497,500.00
2018-06-30-$672,210.00
2018-03-31-$598,159.00-$259,009.00$205,332.00
2017-12-31-$696,124.00-$417,018.00-$133,678.00
2017-09-30-$454,567.00
2017-06-30-$451,092.00
2017-03-31-$657,853.00-$357,397.00
2016-12-31-$556,077.00-$341,808.00-$18,499.00
2016-09-30-$455,476.00
2016-06-30-$524,488.00
2016-03-31-$739,785.00-$57,391.00$3.8M
2015-12-31-$437,055.00-$221,225.00
2015-09-30-$439,477.00-$102,000.00
2015-06-30-$109,119.00-$95,000.00$0.00
2015-03-31-$37,791.00-$9,001.00
2014-12-31-$133,000.00
2014-09-30-$112,000.00-$80,000.00$0.00
2014-06-30-$96,000.00-$87,000.00$0.00
2014-03-31-$370,000.00
2013-12-31-$220,000.00
2013-09-30-$394,000.00-$436,000.00$1,000.00
2011-09-30-$4.52M
2010-09-30-$3.64M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31$1.37M-$2.81M$629,883.00$3.87M
2025-03-31-$3.59M-$1.77M$1.81M
2024-12-31-$5.53M-$4.22M$2.8M$1.96M
2023-12-31-$5M-$3.7M$4.78M
2022-12-31-$3.56M-$1.99M$1.6M
2021-12-31-$4.52M-$2.8M-$9.91M$12.58M
2020-12-31-$2.55M-$1.35M$1.22M
2019-12-31-$1.75M-$487,990.00$250,000.00$670,000.00
2018-12-31-$2.56M-$1.07M$1.05M
2017-12-31-$2.26M-$1.38M-$1.29M
2016-12-31-$2.28M-$1.14M$4.28M
2015-12-31-$1.02M-$381,341.00$1,791.00
2015-06-30-$476,000.00-$378,000.00$1,000.00
2014-06-30-$1.08M-$790,000.00$1,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.